Detalhe da pesquisa
1.
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.
Proc Natl Acad Sci U S A
; 119(41): e2203480119, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197994
2.
Biology-driven therapy advances in high-grade serous ovarian cancer.
J Clin Invest
; 134(1)2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165032
3.
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.
Clin Cancer Res
; 30(6): 1175-1188, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231483
4.
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Adv Sci (Weinh)
; 11(13): e2305212, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263873
5.
DOT1 L Regulates Ovarian Cancer Stem Cells by Activating ß-catenin Signaling.
Mol Cancer Res
; 21(2): 140-154, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36318113
6.
Metabolic dependencies and targets in ovarian cancer.
Pharmacol Ther
; 245: 108413, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059310
7.
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase.
Mol Cancer Ther
; 22(3): 393-405, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622754
8.
FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway.
J Clin Invest
; 132(10)2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349489
9.
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells.
Nat Commun
; 13(1): 4554, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931676
10.
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.
Cancer Res
; 81(15): 3985-4000, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224372
11.
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer.
J Immunother Cancer
; 9(9)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593619
12.
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Cancer Res
; 81(2): 384-399, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172933
13.
FTO-Dependent N 6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.
Cancer Res
; 80(16): 3200-3214, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32606006
14.
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.
Cancers (Basel)
; 11(4)2019 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30965686
15.
Editorial: Novel targets for ovarian cancer stem cells.
Front Oncol
; 13: 1325066, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023161
16.
IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.
JCI Insight
; 3(23)2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518684
17.
Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer.
Sci Rep
; 7(1): 894, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420874
18.
Epigenetic targeting of ovarian cancer stem cells.
Cancer Res
; 74(17): 4922-36, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035395
19.
Decitabine reactivated pathways in platinum resistant ovarian cancer.
Oncotarget
; 5(11): 3579-89, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003579
20.
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.
Clin Cancer Res
; 20(24): 6504-16, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316809